Evaluation of the pharmacokinetics and food intake effect of generic sofosbuvir in healthy Chinese subjects

被引:3
作者
Li, Xin [1 ]
Liu, Yujie [2 ]
Xu, Bing [1 ]
Liu, Lihua [1 ]
Li, Yuan [1 ]
Zhang, Ping [3 ]
机构
[1] Third Hosp Changsha, Dept Pharm, Changsha, Hunan, Peoples R China
[2] Nanjing Chia Tai Tianqing Pharmaceut Co Ltd, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Clin Tech Labs Inc, Nanjing, Jiangsu, Peoples R China
关键词
generic sofosbuvir; pharmacokinetics; food effect; hepatitis C; healthy Chinese; HEPATITIS-C VIRUS; POLYMERASE INHIBITOR; INFECTION;
D O I
10.5414/CP203649
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: Sofosbuvir is an NS5B nucleotide inhibitor that was approved for hepatitis C treatment. Generic sofosbuvir has been produced to improve the affordability. The present study investigated the pharmacokinetics (PK) and safety of generic sofosbuvir as well as the effect of food intake on its PK parameters in healthy Chinese subjects. Materials and methods: This open-label, randomized, multiple-dose, dose-escalating, and food effect trial enrolled 12 healthy Chinese subjects. The subjects received a single oral dose of 400 mg of generic sofosbuvir in fasted state or after a high-fat meal. or 800 mg in fasted state, in a three-way crossover design, and then all subjects were administered with 400 mg daily for 8 days. The PK parameters for sofosbuvir and its metabolites were determined, and the safety was monitored. Results: Sofosbuvir was absorbed rapidly into plasma. with a half-life of 0.46 - 0.48 hours. Plasma exposure to sofosbuvir and its metabolite GS-566500 was increased in an approximately proportional manner to the increased dose. Repeated dosing did not result in drug accumulation in the blood. Sofosbuvir was mainly excreted as the metabolite GS-331007 in the urine. Drug administration after a high-fat meal increased the plasma sofosbuvir exposure by 1.29-fold, without substantially altering the absorption rate. No serious adverse events were observed, and all subjects tolerated the doses well. Conclusion: This generic sofosbuvir was well absorbed, the plasma concentration was increased with an increased dose. and it was safe in healthy subjects. A high-fat meal appeared to promote the bioavailability of sofosbuvir and the metabolite GS-566500. What is known about this subject - Pharmacokinetics of single and multiple dose (400 mg) brand-name sofosbuvir in healthy Chinese subjects under fasting conditions have been studied. What this study adds - This study evaluated the pharmacokinetic profile of generic sofosbuvir in healthy Chinese subjects. - This generic sofosbuvir was well absorbed, and the plasma concentration was increased with an increased dose. A high-fat meal appeared to promote the bioavailability of this drug and the metabolite GS-566500. - Sofosbuvir at doses up to 800 mg was well tolerated.
引用
收藏
页码:230 / 241
页数:12
相关论文
共 50 条
[31]   Evaluation of Olaparib Tablet Safety and Pharmacokinetics in Healthy Chinese Male Subjects [J].
Dong, Ruihua ;
Chen, Jingcheng ;
Guo, Nini ;
Yang, Yingying ;
Wu, Jingxuan ;
Wang, Xiaoru ;
Song, Yuqin ;
Zhang, Xueyuan .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 :5529-5539
[32]   Pharmacokinetics and safety of a new generic lurasidone: a phase I bioequivalence study in healthy Chinese subjects [J].
Liu, Zhengzhi ;
Xue, Jinling ;
Deng, Qiaohuan ;
Wang, Yanli ;
Zhang, Lixiu ;
Liu, Lang ;
Xiao, Nan ;
Chang, Tianying ;
Cui, Yingzi ;
Cheng, Yang ;
Liu, Guangwen ;
Wang, Wanhua ;
Zhou, Yannan ;
Yang, Wei ;
Qu, Xinyao ;
Chen, Jiahui ;
Zhao, Yicheng ;
Wang, Zeyu ;
Yang, Haimiao .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (09) :7051-7060
[33]   Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects [J].
Wang, Yanli ;
Xue, Jinling ;
Su, Zhengjie ;
Cui, Yingzi ;
Liu, Guangwen ;
Yang, Wei ;
Liu, Zhengzhi ;
Chen, Jiahui ;
Ren, Qing ;
Yu, Shuang ;
Cheng, Yang ;
Zhou, Yannan ;
Wang, Wanhua ;
Chen, Xuesong ;
Qu, Dongmei ;
Deng, Qiaohuan ;
Zhao, Yicheng ;
Yang, Haimiao .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (03) :263-270
[34]   Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects [J].
Morcos, Peter N. ;
Guerini, Elena ;
Parrott, Neil ;
Dall, Georgina ;
Blotner, Steven ;
Bogman, Katrijn ;
Sturm, Carolina ;
Balas, Bogdana ;
Martin-Facklam, Meret ;
Phipps, Alex .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (04) :388-397
[35]   Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers [J].
Yazdi K. Pithavala ;
Ying Chen ;
Melvin Toh ;
Paulina Selaru ;
Robert R. LaBadie ;
May Garrett ;
Brian Hee ;
Janessa Mount ;
Grace Ni ;
Karen J. Klamerus ;
Michael A. Tortorici .
Cancer Chemotherapy and Pharmacology, 2012, 70 :103-112
[36]   Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers [J].
Pithavala, Yazdi K. ;
Chen, Ying ;
Toh, Melvin ;
Selaru, Paulina ;
LaBadie, Robert R. ;
Garrett, May ;
Hee, Brian ;
Mount, Janessa ;
Ni, Grace ;
Klamerus, Karen J. ;
Tortorici, Michael A. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) :103-112
[37]   The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects [J].
Song, Ivy H. ;
Zong, Jian ;
Borland, Julie ;
Jerva, Fred ;
Wynne, Brian ;
Zamek-Gliszczynski, Maciej J. ;
Humphreys, Joan E. ;
Bowers, Gary D. ;
Choukour, Mike .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (04) :400-407
[38]   Pharmacokinetics, bioequivalence and safety of two formulations of ticagrelor in healthy Chinese subjects: Effects of food [J].
Dong, Chengmei ;
Zhang, Xiaonan ;
Zhang, Yalan ;
Ouyang, Wenjuan ;
Peng, Daizhuang ;
Li, Xiaomin ;
Li, Dai ;
Qin, Qun .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 132 (04) :313-320
[39]   Effect of food on the single-dose pharmacokinetics and tolerability of savolitinib in Chinese healthy volunteers [J].
Ding, Qichen ;
Ou, Meixian ;
Zhu, Huijuan ;
Wang, Yijun ;
Jia, Jingying ;
Sai, Yang ;
Chen, Qian ;
Wang, Jian .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (01) :210-217
[40]   Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects [J].
Li, Haiyan ;
Zhang, Weijiang ;
Petry, Claire ;
Li, Lindong ;
Fernandez, Elena ;
Kiialainen, Anna ;
Feng, Sheng ;
Hsu, Wanling ;
Li, Li ;
Wei, Yudong ;
Schmitt, Christophe .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (01) :30-38